In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor

Quinn, Frederick and Mondal, Rajesh and Dusthackeer V. N., Azger and Kannan, Palaniyandi and Singh, Amit Kumar and Thiruvengadam, Kannan and Manikkam, Radhakrishnan and A. S., Shainaba and Balasubramanian, Mahizhaveni and Elango, Padmasini and Ebenezer Rajadas, Sam and Bharadwaj, Dinesh and Arumugam, Gandarvakottai Senthilkumar and Ganesan, Suresh and Kumar A. K., Hemanth and Singh, Manjula and Patil, Shripad and U. C. A., Jaleel and Doble, Mukesh and R., Balagurunathan and Tripathy, Srikanth Prasad and Kumar, Vanaja (2023) In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. PLOS ONE, 18 (3). e0282454. ISSN 1932-6203

Archive 202303.pdf - Published Version Download (18MB)

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	In-vivo studies, Transitmycin, potent, Mycobacterium tuberculosis, inhibitor
Subjects:	Tuberculosis > Laboratory Research > Bacteriological
Divisions:	Basic Science Research > Bacteriology
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	01 May 2023 10:36
Last Modified:	01 May 2023 10:36
URI:	http://eprints.nirt.res.in/id/eprint/1946

Actions (login required)

View Item